Cytesi Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series AA

  • Latest Deal Amount
  • $5.5M

  • Investors
  • 3

Cytesi General Information

Description

Developer of biomedical laboratory automation technology designed to support life science research workflows. The company's platform uses a digital microfluidics system with multiple individual pixels and integrated AI-driven lab-on-a-chip capabilities, combined with edge computing and optical inspection tools that automate complex fluid handling and detection processes, enabling research institutions and biotech laboratories to reduce manual bottlenecks, improve throughput, and improve experimental consistency across biomedical screening, synthetic biology, and drug discovery applications.

Contact Information

Website
www.cytesi.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1600 Adams Drive
  • Suite 221
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Other Devices and Supplies
Vertical(s)
Big Data, Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 1600 Adams Drive
  • Suite 221
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytesi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series AA) 13-May-2024 $5.5M Completed Stealth
1. Early Stage VC (Series A) 06-Jun-2022 Completed Stealth
To view Cytesi’s complete valuation and funding history, request access »

Cytesi Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series AA
Series A-2
Series A-1 996,937 $0.000100 8% $0.88 $0.88 1x $0.88 7.04%
Series A 1,468,872 $0.000100 8% $3.06 $3.06 1x $3.06 10.37%
To view Cytesi’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cytesi Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Cytesi Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250041852-A1 Electrowetting-on-dielectric (ewod) system with multiport connection design Pending 02-Aug-2023
US-20250043330-A1 Method for molecule quantification Pending 02-Aug-2023
US-12741282-B2 Electrowetting-on-dielectric (ewod) device Active 19-May-2023
US-20240382965-A1 Electrowetting-on-dielectric (ewod) device Active 19-May-2023
WO-2025240570-A1 Electrowetting-on-dielectric (ewod) device Pending 19-May-2023 B01L3/502792
To view Cytesi’s complete patent history, request access »

Cytesi Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amino Capital Venture Capital Minority
NHH Ventures Corporate Venture Capital Minority
Techlink Ventures Venture Capital Minority
To view Cytesi’s complete investors history, request access »

Ready to get started?

Request a free trial

Cytesi FAQs

  • When was Cytesi founded?

    Cytesi was founded in 2018.

  • Where is Cytesi headquartered?

    Cytesi is headquartered in Menlo Park, CA.

  • What industry is Cytesi in?

    Cytesi’s primary industry is Discovery Tools (Healthcare).

  • Is Cytesi a private or public company?

    Cytesi is a Private company.

  • What is the current valuation of Cytesi?

    The current valuation of Cytesi is .

  • What is Cytesi’s current revenue?

    The current revenue for Cytesi is .

  • How much funding has Cytesi raised over time?

    Cytesi has raised $12.4M.

  • Who are Cytesi’s investors?

    Amino Capital, NHH Ventures, and Techlink Ventures have invested in Cytesi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process